Cervical cancer vaccine bound for clinic; Businesses warned to prepare for vax campaigns;

Vaccine Research

VGX Pharmaceuticals says that the FDA has accepted its IND for an experimental DNA vaccine for cervical cancer. VGX-3100 will go into Phase I in the third quarter. Story

Researchers at the University of Pennsylvania School of Medicine have developed a new technique that tricks the human immune system to respond against multiple strains of bird flu. Release

Sinovac Biotech has begun to recruit patients for a mid-stage study of its bird flu vaccine. Report

Genetically engineered yeast has produced an anti-tumor response in mice. Story

Monash University scientists have started clinical trials to find a successful vaccine against footrot in sheep. Report

Vaccine market

Experts are warning companies in the U.S. to start preparing now for any upcoming flu vaccination programs. Release

WellPoint, one of the largest insurers in the U.S., says that it will reimburse for the new rotavirus vaccine Rotarix. Report

Physicians in the U.K. are being warned of a shortage of vaccines for children. Story

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.